87c6fc59f71d1d3aff4195004ba3233c

NOVACLONE™ ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT

IMMUCOR INC.·III·Colombia INVIMA·Expires June 28, 2026

Device classification

Risk class / Clase de Riesgo: III
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 87c6fc59f71d1d3aff4195004ba3233c
Expire date: June 28, 2026

Authorized company / Fabricante

Name (Spanish): IMMUCOR INC.
Name (English): IMMUCOR INC.

Product use / Uso del Producto

Spanish

ESTE REACTIVO DE AGRUPACIÓN DE SANGRE ESTÁN DESTINADOS PARA SU USO EN PRUEBAS DE PORTAOBJETOS, TUBOS Y MICROPLACAS Y PROPORCIONAN UNA PRUEBA ESPECÍFICA Y CUALITATIVA PARA LA DETECCIÓN DEL ANTÍGENO RH CORRESPONDIENTE EN LOS GLÓBULOS ROJOS HUMANOS.

English

THIS BLOOD POOLING REAGENT IS INTENDED FOR USE IN SLIDE, TUBE AND MICROPLATE TESTS AND PROVIDES A SPECIFIC AND QUALITATIVE TEST FOR THE DETECTION OF THE CORRESPONDING RH ANTIGEN IN HUMAN RED BLOOD CELLS.

About this record

Access comprehensive regulatory information for NOVACLONE™ ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT (NOVACLONE™ ANTI-CII (RH2) HUMAN MONOCLONAL IGM RH TYPING REAGENT) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 87c6fc59f71d1d3aff4195004ba3233c and manufactured by IMMUCOR INC.. The device was registered on June 28, 2026.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.